In our study, we used the AKT inhibitor, MK2206, to treat CRC cells and found that ferroptosis occurred after treatment of MK2206 and GPX4 was obviously inhibited in this process, which enhanced ROS production. The gene discussed is AKT1; the disease is colorectal carcinoma.